Hazlett Burt & Watson Inc. grew its holdings in Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by 14.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,850 shares of the consumer goods maker’s stock after acquiring an additional 475 shares during the period. Hazlett Burt & Watson Inc.’s holdings in Anheuser-Busch InBev SA/NV were worth $253,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of BUD. DAVENPORT & Co LLC increased its position in shares of Anheuser-Busch InBev SA/NV by 36.8% during the 1st quarter. DAVENPORT & Co LLC now owns 2,062,543 shares of the consumer goods maker’s stock valued at $125,389,000 after purchasing an additional 555,362 shares during the last quarter. Renaissance Technologies LLC boosted its position in Anheuser-Busch InBev SA/NV by 672.3% during the 2nd quarter. Renaissance Technologies LLC now owns 600,300 shares of the consumer goods maker’s stock valued at $34,907,000 after acquiring an additional 522,575 shares in the last quarter. Janus Henderson Group PLC purchased a new position in Anheuser-Busch InBev SA/NV in the first quarter valued at about $18,226,000. International Assets Investment Management LLC bought a new position in shares of Anheuser-Busch InBev SA/NV during the 3rd quarter worth approximately $154,640,000. Finally, GFS Advisors LLC lifted its holdings in shares of Anheuser-Busch InBev SA/NV by 56,727.5% during the 3rd quarter. GFS Advisors LLC now owns 196,055 shares of the consumer goods maker’s stock valued at $12,996,000 after purchasing an additional 195,710 shares during the last quarter. Institutional investors own 5.53% of the company’s stock.
Wall Street Analyst Weigh In
BUD has been the topic of a number of research analyst reports. Evercore ISI raised shares of Anheuser-Busch InBev SA/NV to a “strong-buy” rating in a report on Monday, September 30th. TD Cowen downgraded shares of Anheuser-Busch InBev SA/NV from a “buy” rating to a “hold” rating and increased their price target for the stock from $68.00 to $88.00 in a report on Tuesday, October 8th. Citigroup raised Anheuser-Busch InBev SA/NV from a “neutral” rating to a “buy” rating in a report on Tuesday, October 1st. Barclays upgraded shares of Anheuser-Busch InBev SA/NV to a “strong-buy” rating in a research report on Wednesday, October 9th. Finally, Morgan Stanley lifted their target price on shares of Anheuser-Busch InBev SA/NV from $68.50 to $73.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Anheuser-Busch InBev SA/NV currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.00.
Anheuser-Busch InBev SA/NV Stock Performance
Shares of BUD opened at $58.55 on Tuesday. The stock has a market capitalization of $105.23 billion, a P/E ratio of 18.07, a P/E/G ratio of 1.63 and a beta of 1.12. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 0.69. Anheuser-Busch InBev SA/NV has a 1 year low of $57.09 and a 1 year high of $67.49. The company’s fifty day moving average is $63.89 and its two-hundred day moving average is $62.17.
About Anheuser-Busch InBev SA/NV
Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands.
Recommended Stories
- Five stocks we like better than Anheuser-Busch InBev SA/NV
- Profitably Trade Stocks at 52-Week Highs
- Intel: Is Now the Time to Be Brave?Â
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Tickers Leading a Meme Stock Revival
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding BUD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report).
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.